PEITHO
2014
Pulmonary Embolism Thrombolysis trial
In 1,006 patients with intermediate-risk pulmonary embolism, tenecteplase reduced haemodynamic decompensation but increased major and intracranial bleeding compared with heparin alone.
Result
Efficacy: Death or haemodynamic decompensation at 7 daysOR 0.44
Below 1 favours tenecteplase, above 1 favours heparin alone.
- Absolute difference
- 3.0 points
The absolute difference is derived from the event rates.
Also reported: Intracranial haemorrhage 2.0 % vs 0.2 %.
- Subtopic
- Pulmonary embolism
- Design
- Double-blind RCT
- Relevance
- Practice-defining: a trial the guidelines cite as evidence.
- Source
- Meyer G, et al. N Engl J Med. 2014;370(15):1402-1411.doi 10.1056/NEJMoa1302097
Discussion & critique
Net harm from routine full-dose fibrinolysis in intermediate-risk PE: class III. Drove interest in reduced-dose lysis and catheter-directed therapy.